NIH licensed COVID-19 research tools and early-stage technologies to WHO program
On May 12, 2022, the U.S. National Institutes of Health announced that it had licensed 11 COVID-19 research…
Lucira filed for authorization of first-of-its-Kind COVID-19 & flu at-home molecular test
On May 11, 2022, Lucira Health announced that it had submitted a request to the U.S. Food and…
Lucira received CE Mark for both COVID-19 & flu and COVID-19 molecular tests
On May 9, 2022, Lucira Health announced that both its COVID-19 & Flu and COVID-19 molecular tests have…
WHO informed of a confirmed case of monkeypox in an individual who travelled from the United Kingdom to Nigeria
On May 7, 2022, WHO was informed of a confirmed case of monkeypox in an individual who travelled…
NIH launched clinical trial of Epstein-Barr virus vaccine
On May 6, 2022, the National Institute of Allergy and Infectious Diseases (NIAID) announced that it had launched…
WHO reported 14.9 million excess deaths associated with the COVID-19 pandemic in 2020 and 2021
On May 5, 2022, the World Health Organization (WHO) reported estimates that show the full death toll associated…
U.S. EPA and State of Florida approved second pilot project with Oxitec Friendlyï¾™ mosquitoes in the Florida Keys
On May 4, 2022, Oxitec announced approval from the Florida Department of Agriculture and Consumer Services, including reviews…
USDA confirmed highly pathogenic Avian influenza in Oklahoma
On May 1, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
USDA confirmed highly pathogenic Avian influenza in Alaska
On Apr. 30, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
USDA confirmed highly pathogenic Avian influenza in Vermont
On Apr. 29, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the the…
Moderna finalized plan for long-term strategic partnership with the Government of Canada
On Apr. 29, 2022, Moderna announced its plan to build a state-of-the-art mRNA vaccine manufacturing facility in Quebec…
Moderna filed to expand conditional Marketing Authorization for COVID-19 vaccine to include children six months to under six years in the EU
On Apr. 29, 2022, Moderna announced that it had submitted for a variation to the conditional marketing authorization…
Moderna filed for authorization of Its COVID-19 vaccine in young children six months to under six years of age
On Apr. 28, 2022, Moderna announced that it had submitted a request for emergency use authorization (EUA) for…
U.S. case of Human avian influenza A(H5) virus reported
On Apr. 28, 2022, Centers for Disease Control and Prevention (CDC) reported that a person had tested positive…
USDA took action to ensure continued rapid response to highly hathogenic Avian influenza in the U.S.
On Apr. 27, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service (APHIS) announced that…
USDA issued a conditional license for mink Coronavirus
On Apr. 27, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service announced it had…
Evolution of DNA
he Evolution of DNA is an Illustration with the very small, requiring magnification, to the very large. Cast…
Vekluryï¾® (Remdesivir) was first and only approved treatment for pediatric patients under 12 years of age with COVID-19
On Apr. 25, 2022, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) had approved a…
Novavax announced initiationof COVID-19 vaccine booster study in adolescents in phase 3 PREVENT-19 trial
On Apr. 22, 2022, Novavax announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination…
WHO recommened Paxlovid for high-risk COVID patients
On Apr. 22, 2022, the WHO made a strong recommendation for nirmatrelvir and ritonavir, sold under the name…
CureVac and GSKï¾’s bivalent second-generation mRNA accine candidate shown to be highly effective against SARS-CoV-2 variants
On Apr. 21, 2022, CureVac announced preclinical data demonstrating immune responses and protective efficacy of a bivalent second-generation…
Initial results from Novavax’ COVID-19-Influenza vaccine trial were first to show feasibility of combination vaccine
On Apr. 20, 2022, Novavax announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination…
Codiak announced new preclinical data supporting development of broadly protective pan beta-Coronavirus vaccine
On Apr. 20, 2022, Codiak BioSciences announced new preclinical data from its pan beta-coronavirus vaccine program, which aims…
Tonix Pharm announced results of retrospective observational database study in over 50,000 long COVID patients
On Apr. 20, 2022, Tonix Pharmaceuticals announced the results of a retrospective observational database study in over 50,000…
Novavax announced initial results from COVID-19-Influenza vaccine trial were first to show feasibility of combination vaccine
On Apr. 20, 2022, Novavax announced initial results from the Phase 1/2 clinical trial of its COVID-Influenza Combination…
Moderna announced clinical update on bivalent COVID-19 booster platform
On Apr. 19, 2022, Moderna announced new clinical data on its bivalent COVID-19 booster platform including data on…
USDA confirmed highly pathogenic Avian influenza in Pennsylvania and Utah
On Apr. 16, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
USDA confirmed highly pathogenic Avian influenza in Idaho
On Apr. 15, 2022, the U.S. Department of Agricultureï¾’s Animal and Plant Health Inspection Service confirmed the presence…
Pfizer and BioNTech data demonstrated high immune response following booster dose of COVID-19 vaccine in children 5 through 11 years of age
On Mar. 14, 2022, Pfizer and BioNTech announced positive results from a Phase 2/3 clinical trial evaluating the…
Regeneron antibody cocktail approved by European Commission to treat and prevent COVID-19
On Nov. 12, 2021, Regeneron announced that the U.S. Food and Drug Administration had extended by three months…